Carlito syrichta      CAMK/PIM


※ PIM family introduction

    PIM consists of three members, PIM-1, PIM-2 and PIM-3. Sequence analysis shows that PIM-1 and PIM-2 share a sequence identity of 61%, whereas PIM-1 and PIM-3 are 77%. PIM kinases play an important role in cancer. PIM-1 and PIM-2 transgenic mice overexpression these genes have been observed to develop lymphomas. In addition, PIM-1 is over expressed in c-myc transgene driven prostate tumors in mice. In human, PIM-1 and PIM-2 are involved in prostate cancer development. Studies show that PIM-3 is over expressed in colorectal, pancreatic and hepatocellular carcinoma. The mechanisms that PIMs implicated in cancer have been reported that PIMs act as key regulator in several major proliferative and survival signaling pathways or influence the activity of specific cell cycle molecules and changes in gene expression (1).

Reference
1. Isaac, M., Siu, A. and Jongstra, J. (2011) The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms. Drug Resist Updat, 14, 203-211. PMID: 21601509


There are 4 genes.  Reviewed (0 or Unreviewed (4

No.StatusiEKPD IDEnsemble Gene IDUniProt AccessionGene Name
1
iEKPD-Cas-0226
ENSTSYG00000010030.2
2
iEKPD-Cas-0372
ENSTSYG00000029407.1
A0A1U7TNX6
PIM1
3
iEKPD-Cas-0379
ENSTSYG00000030255.1
A0A1U7U333
PIM2
4
iEKPD-Cas-0400
ENSTSYG00000032442.1
A0A1U7UG24
PIM3